• About
    • Adcendo
    • Leadership team
    • Board of Directors
  • Pipeline
    • Our Pipeline
    • Key publications
  • Patients
    • For Patients
    • Expanded Access Policy
  • Investors
    • Press releases and Media
    • Our investors
  • Your careers and our values
  • Contact

Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells (2002)

Apr 26, 2002

Recent Posts

  • Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors
  • Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates
  • Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline
  • Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
  • Adcendo ApS to Participate in Upcoming September Investor Conferences

Recent Comments

No comments to show.

Contact Us

Adcendo ApS
For all inquiries, please contact adcendo
via the e-mail address info@adcendo.com

Connect now  

Cookie Policy
Privacy Policy
Job Applicant Privacy Notice
© Adcendo ApS, All rights reserved 2025

Connect now